DeRenzo C - Search Results

1

DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.

Kirk AM, Crawford JC, Chou CH, Guy C, Pandey K, Kozlik T, Shah RK, Chung S, Nguyen P, Zhang X, Wang J, Bell M, Mettelman RC, Allen EK, Pogorelyy MV, Kim H, Minervina AA, Awad W, Bajracharya R, White T, Long D Jr, Gordon B, Morrison M, Glazer ES, Murphy AJ, Jiang Y, Fitzpatrick EA, Yarchoan M, Sethupathy P, Croft NP, Purcell AW, Federico SM, Stewart E, Gottschalk S, Zamora AE, DeRenzo C, Strome SE, Thomas PG. Kirk AM, et al. Among authors: derenzo c. Cell Rep Med. 2024 Mar 19;5(3):101469. doi: 10.1016/j.xcrm.2024.101469. Cell Rep Med. 2024. PMID: 38508137 Free PMC article.

2

P53 regulates the migration of mesenchymal stromal cells in response to the tumor microenvironment through both CXCL12-dependent and -independent mechanisms.

Lin SY, Dolfi SC, Amiri S, Li J, Budak-Alpdogan T, Lee KC, Derenzo C, Banerjee D, Glod J. Lin SY, et al. Among authors: derenzo c. Int J Oncol. 2013 Dec;43(6):1817-23. doi: 10.3892/ijo.2013.2109. Epub 2013 Sep 23. Int J Oncol. 2013. PMID: 24064862 Free PMC article.

3

Nonoperative management of abdominoscrotal hydroceles in an infant.

De Renzo CC, Barone JG. De Renzo CC, et al. Urology. 2006 Aug;68(2):428.e9-11. doi: 10.1016/j.urology.2006.03.023. Urology. 2006. PMID: 16904478

4

Genetically modified T cells to target glioblastoma.

Krebs S, Rodríguez-Cruz TG, Derenzo C, Gottschalk S. Krebs S, et al. Among authors: derenzo c. Front Oncol. 2013 Dec 31;3:322. doi: 10.3389/fonc.2013.00322. Front Oncol. 2013. PMID: 24427741 Free PMC article. Review.

5

Genetically modified T-cell therapy for osteosarcoma.

DeRenzo C, Gottschalk S. DeRenzo C, et al. Adv Exp Med Biol. 2014;804:323-40. doi: 10.1007/978-3-319-04843-7_18. Adv Exp Med Biol. 2014. PMID: 24924183 Free PMC article. Review.

6

Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update.

DeRenzo C, Gottschalk S. DeRenzo C, et al. J Clin Cell Immunol. 2016 Apr;7(2):417. doi: 10.4172/2155-9899.1000417. Epub 2016 Apr 29. J Clin Cell Immunol. 2016. PMID: 27313973 Free PMC article. No abstract available.

7

The Landscape of CAR T Cells Beyond Acute Lymphoblastic Leukemia for Pediatric Solid Tumors.

DeRenzo C, Krenciute G, Gottschalk S. DeRenzo C, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:830-837. doi: 10.1200/EDBK_200773. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231350 Free PMC article. Review.

8

Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.

DeRenzo C, Lam C, Rodriguez-Galindo C, Rapkin L, Gottschalk S, Venkatramani R. DeRenzo C, et al. Pediatr Blood Cancer. 2019 Jan;66(1):e27469. doi: 10.1002/pbc.27469. Epub 2018 Oct 14. Pediatr Blood Cancer. 2019. PMID: 30318742 Free PMC article.

9

Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors.

DeRenzo C, Gottschalk S. DeRenzo C, et al. Front Immunol. 2019 Feb 15;10:218. doi: 10.3389/fimmu.2019.00218. eCollection 2019. Front Immunol. 2019. PMID: 30828333 Free PMC article. Review.

10

Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s.

DeRenzo C, Gottschalk S. DeRenzo C, et al. Adv Exp Med Biol. 2020;1257:109-131. doi: 10.1007/978-3-030-43032-0_10. Adv Exp Med Biol. 2020. PMID: 32483735 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters